Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Enanta Pharmaceuticals, Inc.”

218 pharma patents match "Enanta Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 218
Index total 30,257
Page 6 / 10

Quick answer

This filtered view shows 218 pharmaceutical patents matching "Enanta Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

218 results for “Enanta Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 8927709

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jan 6, 2015 · Expires Jan 1, 2035

    granted

  2. US 8906853

    [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection

    Enanta Pharmaceuticals, Inc. · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  3. US 8846638

    Macrocyclic nucleoside phosphoramidate derivatives

    Enanta Pharmaceuticals, Inc. · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  4. US 8822700

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  5. US 8815928

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  6. US 8809264

    Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  7. US 8785487

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  8. US 8785377

    Tetrazolyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  9. US 8778938

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  10. US 8759332

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted

  11. US 8703938

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  12. US 8697704

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  13. US 8685917

    Cyclosporin analogues

    Enanta Pharmaceuticals, Inc. · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  14. US 8673954

    Benzimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted

  15. US 8653070

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 18, 2014 · Expires Feb 13, 2034

    granted

  16. US 8648037

    Macrocyclic proline derived HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 11, 2014 · Expires Feb 6, 2034

    granted

  17. US 8637561

    Linked diimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted Jan 28, 2014 · Expires Jan 23, 2034

    granted

  18. US 8623814

    Antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  19. US 8609648

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  20. US 8575119

    2′-chloroacetylenyl substituted nucleoside derivatives

    Enanta Pharmaceuticals, Inc. · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted

  21. US 8507522

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  22. US 8501681

    Macrocyclic hepatitis C virus serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  23. US 8501682

    Difluorinated tripeptides as HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  24. US 8481483

    Cyclosporin analogues

    Enanta Pharmaceuticals, Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.